Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771517018 | Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3771518011 | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Is a | Product containing sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Has manufactured dose form | Vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Is a | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Has active ingredient | Sulfabenzamide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Has active ingredient | Sulfathiazole | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Has active ingredient | Sulfacetamide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | Is a | True | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | True | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR